Endometrial Endometrioid Adenocarcinoma with Squamous Differentiation
📧 Sign up to get email alerts when something new happens for Endometrial Endometrioid Adenocarcinoma with Squamous Differentiation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer [Phase 2]
Phase 2 clinical trial of trebananib for persistent or recurrent endometrial cancer has completed, with results posted in 2017.